Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

TWI PHARMS

  • FDA Approval
  • Dec. 27, 2023, 09:49 UTC
  • 31
  • 0 comments

FDA approve ATENOLOL

Comment Full text

USWM

  • FDA Approval
  • Dec. 27, 2023, 09:49 UTC
  • 29
  • 0 comments

FDA approve NADOLOL

Comment Full text

AMPHASTAR PHARMS INC

  • FDA Approval
  • Dec. 27, 2023, 09:49 UTC
  • 25
  • 0 comments

FDA approve COSYNTROPIN

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Dec. 27, 2023, 09:49 UTC
  • 30
  • 0 comments

FDA approve FLUOXETINE HYDROCHLORIDE

Comment Full text

ACI

  • FDA Approval
  • Dec. 27, 2023, 09:49 UTC
  • 32
  • 0 comments

FDA approve TRAMADOL HYDROCHLORIDE

Comment Full text

RISING

  • FDA Approval
  • Dec. 27, 2023, 09:49 UTC
  • 32
  • 0 comments

FDA approve URSODIOL

Comment Full text

COHERUS BIOSCIENCES INC

  • FDA Approval
  • Dec. 22, 2023, 19:35 UTC
  • 38
  • 0 comments

FDA approve PEGFILGRASTIM-CBQV

Comment Full text

BRISTOL MYERS SQUIBB

  • FDA Approval
  • Dec. 22, 2023, 17:32 UTC
  • 38
  • 0 comments

FDA approve ENASIDENIB MESYLATE

Comment Full text

HOSPIRA

  • FDA Approval
  • Dec. 22, 2023, 17:32 UTC
  • 35
  • 0 comments

FDA approve MEPIVACAINE HYDROCHLORIDE

Comment Full text

EXELA PHARMA

  • FDA Approval
  • Dec. 22, 2023, 17:22 UTC
  • 36
  • 0 comments

FDA approve CYSTEINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 587
  • 588
  • 589
  • 590
  • 591
  • Next

Search

News categories

  • Technical Exchange News(11766)
  • Event(4289)
  • SEC News(235974)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143471)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin